Megan Elizabeth Burd is a pharmacist who is specialized in Oncology in Louisville, Kentucky. Patients can reach her at 529 S Jackson St, Louisville or contact her on 502-561-7423. Active license number of Megan Elizabeth Burd is 019201 for Oncology in Kentucky. Megan Elizabeth Burd is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Megan Elizabeth Burd speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Megan Elizabeth Burd
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
529 S Jackson St, Louisville, Kentucky, 40202
Phone:
502-561-7423
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Megan Elizabeth Burd are as mentioned below.
NPI Number:
1073222113
NPI Enumeration Date:
17 Nov, 2022
NPI Last Update On:
17 Nov, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Megan Elizabeth Burd are as mentioned below.
Specialization
License Number
State
Status
Oncology
019201
Kentucky
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
529 S Jackson St, Louisville, Kentucky
Zip:
40202-3229
Phone Number:
502-561-7423
Fax Number:
--
Patients can reach Megan Elizabeth Burd at 529 S Jackson St, Louisville, Kentucky or can call on phone at 502-561-7423.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.